Results 1 to 10 of about 696,036 (402)
Extrachromosomal DNA (ecDNA) amplification promotes intratumoral genetic heterogeneity and accelerated tumor evolution1–3; however, its frequency and clinical impact are unclear.
Amit D Gujar, Eunhee Yi, Jens Luebeck
exaly +2 more sources
Intragenic origins due to short G1 phases underlie oncogene-induced DNA replication stress
Oncogene-induced DNA replication stress contributes critically to the genomic instability that is present in cancer. However, elucidating how oncogenes deregulate DNA replication has been impeded by difficulty in mapping replication initiation sites on ...
Thanos D Halazonetis
exaly +2 more sources
Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancer. [PDF]
Pregnancy-associated breast cancers (PABCs) are tumors diagnosed during pregnancy or up to 5 years following parturition, and are usually high-grade, connective tissue-rich, and estrogen receptor (ER)/progesterone receptor-negative. Little is known about
Aina, OH+7 more
core +27 more sources
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences [PDF]
Julian Downward+8 more
openalex +2 more sources
New Insight into microRNA Functions in Cancer: Oncogene–microRNA–Tumor Suppressor Gene Network
Tumorigenesis is a multi-step and complex process with multi-factors involved. Deregulated oncogenes and tumor suppressor genes (TSGs) induced by genetic and epigenetic factors are considered as the driving force in the development and progression of ...
Yi Cui, Kecheng Zhou
exaly +2 more sources
A microRNA polycistron as a potential human oncogene
David Mu, Carlos Cordon-cardo
exaly +2 more sources
Extrachromosomal oncogene amplification in tumour pathogenesis and evolution
Paul S Mischel+2 more
exaly +2 more sources
Editorial Expression of Concern: Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: Pathological significance in early- and late-onset breast carcinoma [PDF]
Satyabrata Sinha+5 more
doaj +2 more sources
P110α is a member of the phosphoinositide 3-kinase (PI3K) enzyme family that functions downstream of RAS. RAS proteins contribute to the activation of p110α by interacting directly with its RAS binding domain (RBD), resulting in the promotion of many ...
Mohamed Ismail+17 more
doaj +1 more source
Background Non-small cell lung cancer (NSCLC) patients bearing targetable oncogene alterations typically derive limited benefit from immune checkpoint blockade (ICB), which has been attributed to low tumor mutation burden (TMB) and/or PD-L1 levels.
M. Negrão+37 more
semanticscholar +1 more source